Scilex Holding Company Current Assets
Scilex Holding Company (SCLX) had Current Assets of $36.23 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $36.23M.
- 2026-03-31: Assets, Current $41.97M.
- 2025-12-31: Assets, Current $38.36M.
- 2025-09-30: Assets, Current $16.49M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $36.23M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $41.97M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $38.36M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $16.49M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $33.67M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $28.70M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $41.55M 10-K · filed 2026-04-10 | |
| 2024-09-30 | $39.85M 10-Q · filed 2025-01-17 | |
| 2024-06-30 | $50.42M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $37.74M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $46.78M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $25.48M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $69.25M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $31.10M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $29.61M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $165.75K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $612.85K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $524.34K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $23.00M 10-K · filed 2023-03-07 | $512.46K 10-K · filed 2022-02-24 |
| 2021-09-30 | $232.18K 10-Q/A · filed 2021-12-08 | |
| 2021-06-30 | $491.98K 10-Q/A · filed 2021-08-24 | |
| 2021-03-31 | $661.30K 10-Q · filed 2021-07-23 | |
| 2020-12-31 | $30.51K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |